Literature DB >> 9099182

Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease.

Y Kuwabara1, Y Ichiya, M Sasaki, T Yoshida, K Masuda, T Matsushima, M Fukui.   

Abstract

BACKGROUND AND
PURPOSE: We have previously reported that cerebral blood flow decreased and oxygen extraction fraction and cerebral blood volume increased in pediatric patients with moyamoya disease, whereas these values did not change significantly in adult patients. In this study, we measured the cerebrovascular response to hypercapnia using 15O H2O positron emission tomography (PET) in each group of patients. These data were also compared with the oxygen extraction fraction and transit time (cerebral blood volume/cerebral blood flow) measured by 15O PET.
METHODS: The subjects consisted of 20 patients with moyamoya disease (7 pediatric and 13 adult patients). Cerebral blood flow was measured by the 15O H2O bolus injection method at the resting state and during the inhalation of 5% CO2. Cerebrovascular CO2 response was estimated as the percentage change of cerebral blood flow per 1 mm Hg change of PaCO2. Oxygen extraction fraction and transit time were measured by the 15O steady-state method.
RESULTS: Cerebrovascular response to hypercapnia severely decreased over the cerebral cortices in both pediatric and adult patients with moyamoya disease when compared with those of normal control subjects, and there was no significant difference between pediatric and adult patients. A significant correlation was observed between the CO2 response and transit time, whereas no significant correlation was seen between the CO2 response and oxygen extraction fraction.
CONCLUSIONS: Our study revealed that the cerebral hemodynamic reserve capacity decreased to an equal degree in both pediatric and adult patients with moyamoya disease. This finding may thus help to explain the occurrence of transient ischemic attack in adult patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099182     DOI: 10.1161/01.str.28.4.701

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography.

Authors:  O Togao; F Mihara; T Yoshiura; A Tanaka; T Noguchi; Y Kuwabara; K Kaneko; T Matsushima; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

Review 2.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

3.  Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

Authors:  C Heyn; J Poublanc; A Crawley; D Mandell; J S Han; M Tymianski; K terBrugge; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

4.  Moyamoya disease, revascularisation surgery and anaesthetic considerations.

Authors:  Yashar Ilkhchoui; Pramod V Panikkath; Hugh Martin
Journal:  BMJ Case Rep       Date:  2014-01-08

5.  Moyamoya disease in which pentazocine treatment caused cerebral infarction.

Authors:  Yoshinori Matsuoka; Makoto Hashizume
Journal:  BMJ Case Rep       Date:  2010-11-09

6.  Electroencephalographic features in pediatric patients with moyamoya disease in China.

Authors:  Jia Lu; Qing Xia; Tuanfeng Yang; Jun Qiang; Xianzeng Liu; Xun Ye; Rong Wang
Journal:  Chin Neurosurg J       Date:  2020-01-13

7.  Endovascular treatment of basilar tip aneurysms associated with moyamoya disease.

Authors:  K Arita; K Kurisu; S Ohba; M Shibukawa; H Kiura; S Sakamoto; T Uozumi; T Nakahara
Journal:  Neuroradiology       Date:  2003-05-28       Impact factor: 2.804

8.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

Review 9.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

10.  Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings.

Authors:  Zhiyong Shi; Guofeng Ma; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2020-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.